Intercept Pharmaceuticals Inc (ICPT)

NASDAQ
16.56
-1.20(-6.76%)
Pre Market
16.01
-0.55(-3.32%)
- Real-time Data
  • Volume:
    881,448
  • Bid/Ask:
    16.02/17.70
  • Day's Range:
    16.53 - 17.58

ICPT Overview

Prev. Close
17.76
Day's Range
16.53-17.58
Revenue
354.34M
Open
17.22
52 wk Range
11.6-38.89
EPS
-3.25
Volume
881,448
Market Cap
489.3M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
847,818
P/E Ratio
-
Beta
1.36
1-Year Change
-39.67%
Shares Outstanding
29,546,974
Next Earnings Date
Feb 24, 2022
What is your sentiment on Intercept Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Intercept Pharmaceuticals Inc Company Profile

Employees
498

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat progressive non-viral liver diseases with unmet medical need utilizing its bile acid chemistry. The Company’s product candidates include Ocaliva (obeticholic or OCA) for liver fibrosis due to nonalcoholic steatohepatitis (NASH), OCA and Bezafibrate, and Other Product Candidates. The Company’s marketed product, Ocaliva, is a farnesoid X receptor (FXR) agonist for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. In addition to commercializing OCA for PBC, it is also developing OCA for additional indications, including NASH. The Company is also developing product candidates in various stages of clinical and preclinical development.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellSellSell
Technical IndicatorsStrong SellStrong SellNeutralBuyStrong Sell
SummaryStrong SellStrong SellNeutralNeutralStrong Sell
  • 7M Volume.15.33$(-8.48%) Waiting for a pump. :)
    0
    • I bought this yesterday now I am bagholder.
      0
    • I bought too..Why u think u are a bagholder?
      0
  • Just added some shares. This ca be very profitable.... or not :0)
    1
    • Hope so...
      0
  • Target price? A lot of patience with this enterprise
    1
    • 25 USD
      0
    • at this rate under 10😂😂😂
      0
    • For my health....better up to 50 XD
      0
  • Target price? A lot of patience with this enterprise
    1
    • Anybody here?
      0
      • YEEHHAAA
        3
        • 11$
          1
          • lol
            0
          • Lol
            0
          • lol?
            0
        • belle chute
          0
          • Trash
            0
            • Hello, potential for hold 2021, price prediction?
              0
              • 120usd
                0
              • 0
              • If February application goes through, we may see 50 by March
                0
            • very good entry point for long
              0
              • scared even to scalp this *******
                0
                • Trash
                  0
                  • This is piece of *******scam
                    0
                    • now ready to fly
                      0
                      • Does anyone know what happened in June 29th to shares fall like that?
                        0
                        • The stock has made scant headway after a 40% plunge on June 29 when it announced the receipt of a Complete Response Letter (CRL) regarding its U.S. marketing application for OCA for liver fibrosis due to NASH.
                          0
                      • Low 40's will be tested.....Longggggg Summmerrr = Dead Money here
                        0
                        • what's the future of this stock
                          0
                          • 150$
                            0
                          • 40 at least then 50, 60
                            0
                        • To keep it or not to keep it?
                          0
                          • stonks only go up
                            0
                            • Big time disappointment !!!
                              0
                              • 3 Day Rule traders!!!!!!!
                                0
                                • What is 3 day Rule
                                  0
                                • What is 3 fay rule
                                  0
                                • This company is nothing on B/S, looks like a penny stock
                                  0
                              • It may be a good buy for small  investors around $73-74 levels
                                1
                                • Why the 15% drop since 31/12/2019?
                                  0
                                  • buyzone 62-70. first target 120-140. 2nd target 300.
                                    1
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.